Skip to main content
. 2019 Feb 11;14(2):e0212036. doi: 10.1371/journal.pone.0212036

Table 2. Baseline LSM and HA for predicting death, liver-related death and first cirrhotic complication during follow-up.

The tables shows the used cut-offs for LSM and HA as well as cut-offs yielding 90% sensitivity or specificity for each individual test.

Cut-off Patients above cut-off (%) Sens (%) Spe (%) PPV (%) NPV (%)
Baseline LSM (kPa) All-cause death AUC 0.70 (95% CI 0.62–0.78)
LSM 10–16.9kPa
LSM 17-75kPa
10 31.6 61.8 72.3 22.5 93.6
17 14.7 47.1 90.0 40.0 92.9
Cut-off for 90% sensitivity 5 79.7 90.0 21.6 12.9 94.2
Cut-off for 90% specificity 17 14.7 47.1 90.0 40.0 92.9
Liver-related deatha AUC 0.93 (95% CI 0.89–0.98)
LSM 10–16.9kPa 10 31.6 96.3 71.5 14.0 99.8
LSM 17-75kPa 17 14.7 85.2 88.7 26.7 99.2
Cut-off for 90% sensitivity 14 20.1 90.0 83.2 20.5 99.4
Cut-off for 90% specificity 19 13.0 85.2 90.0 29.1 99.2
First cirrhotic complicationb AUC 0.89 (95% CI 0.82–0.97)
LSM 10–16.9kPa 10 28.1 90.0 75.4 17.0 99.3
LSM 17-75kPa 17 11.2 66.7 91.9 31.5 98.0
Cut-off for 90% sensitivity 12 20.4 90.0 83.5 22.8 99.3
Cut-off for 90% specificity 15 12.8 73.3 90.0 29.0 98.4
Baseline HA (ng/mL) All-cause death AUC 0.68 (95% CI 0.60–0.76)
Median HA for group 17-75kPa 200 9.3 39.4 95.4 52.7 92.4
Cut-off for 90% sensitivity 14 84.9 90.0 15.9 12.2 92.4
Cut-off for 90% specificity 117 14.6 45.5 90.0 37.2 92.7
Liver-related deatha AUC 0.93 (95% CI 0.88–0.99)
Median HA for group 17-75kPa 200 9.3 76.9 94.6 40.7 98.8
Cut-off for 90% sensitivity 40 45.2 90.0 57.6 9.3 99.2
Cut-off for 90% specificity 125 14.0 84.6 90.0 29.0 99.2
First cirrhotic complicationb AUC 0.89 (95% CI 0.83–0.94)
Median HA for group 17-75kPa 200 6 46.7 93.3 28 96.9
Cut-off for 90% sensitivity 62 26.3 90 73.8 16 99
Cut-off for 90% specificity 131 10.1 70 90 28 98.2
Combined modelc All-cause death AUC 0.74 (95% CI 0.67–0.80)d
Liver-related deatha AUC 0.94 (95% CI 0.91–0.98)d
First cirrhotic complicationb AUC 0.91 (95% CI 0.85–0.98)

Sens; sensitivity. Spe; Specificity. PPV; positive predictive value. NPV; negative predictive value

a Model for liver-related deaths for patients >30 years of age.

b Model for cirrhotic complications excluding the patients <30 years and the 29 patients who already had a complication at baseline.

cCombined model for LSM and HA. Cut-offs are displayed in the supplementary material (S4 Table).

dSignificantly higher AUC for death/death from liver disease than bLSM or bHA alone (p = 0.034 and 0.001/0.001 and 0.006, respectively)